Morgan Stanley’s Immune Design Corp. IMDZ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2019
Q2
Sell
-7,073
Closed -$41K 6964
2019
Q1
$41K Sell
7,073
-136,979
-95% -$794K ﹤0.01% 5759
2018
Q4
$188K Buy
144,052
+38,803
+37% +$50.6K ﹤0.01% 5310
2018
Q3
$363K Buy
105,249
+32,672
+45% +$113K ﹤0.01% 5165
2018
Q2
$330K Buy
72,577
+307
+0.4% +$1.4K ﹤0.01% 5331
2018
Q1
$239K Buy
72,270
+6,600
+10% +$21.8K ﹤0.01% 5397
2017
Q4
$256K Sell
65,670
-68,622
-51% -$268K ﹤0.01% 5324
2017
Q3
$1.39M Buy
134,292
+74,640
+125% +$773K ﹤0.01% 4197
2017
Q2
$582K Buy
59,652
+41,354
+226% +$403K ﹤0.01% 4703
2017
Q1
$124K Sell
18,298
-26,443
-59% -$179K ﹤0.01% 5522
2016
Q4
$247K Buy
44,741
+42,063
+1,571% +$232K ﹤0.01% 5273
2016
Q3
$20K Sell
2,678
-2,150
-45% -$16.1K ﹤0.01% 5918
2016
Q2
$40K Buy
4,828
+4,247
+731% +$35.2K ﹤0.01% 5607
2016
Q1
$8K Buy
581
+343
+144% +$4.72K ﹤0.01% 6201
2015
Q4
$5K Sell
238
-1,697
-88% -$35.7K ﹤0.01% 6400
2015
Q3
$24K Sell
1,935
-2,077
-52% -$25.8K ﹤0.01% 6000
2015
Q2
$83K Sell
4,012
-51,226
-93% -$1.06M ﹤0.01% 5680
2015
Q1
$1.17M Buy
55,238
+47,127
+581% +$995K ﹤0.01% 4010
2014
Q4
$250K Buy
8,111
+7,936
+4,535% +$245K ﹤0.01% 5109
2014
Q3
$3K Buy
+175
New +$3K ﹤0.01% 6426